For another year, U.S. News & World Report has recognized the Gastroenterology (GI) program at Children’s Medical Center as one of the very best in the nation to treat children with common and complex gastrointestinal and hepatobiliary disorders.
And we couldn’t agree more. After all, the GI program uses state-of-the-art diagnostic and therapeutic procedures to provide advanced treatment and research to more than 900 patients per month.
But it’s not just the amount of children the program treats, but the expert and quality care that is provided to each. Here are just a few other reasons why we think U.S. News once again recognized the GI program at Children’s:
• Specialty centers within the program encompass centers for inflammatory bowel disease (IBD), irritable bowel syndrome, abdominal pain and motility disorders, liver disease disorders and intestinal failure/rehabilitation. Liver transplantation is provided in collaboration with the Solid Organ Transplant team.
• The Southwestern Center for Pediatric Inflammatory Bowel Disease (IBD) at Children’s is the only center of its kind in North Texas to offer a comprehensive multidisciplinary approach to the diagnosis, treatment, education and research of pediatric IBD. The team sees infants and children who suffer from chronic recurring inflammation of the intestines, including IBD, Crohn’s disease, ulcerative colitis and indeterminate colitis.
• A dedicated psychiatrist is part of the GI treatment team. Multidisciplinary care is provided for patients with GI, liver and nutritional disorders through collaboration with dietitian services, pulmonology and pathology, among others.
• Children’s is a founding member of Improve Care Now, a 30-center collaboration to improve the quality of care provided to children with IBD.
• The program has a strong emphasis on research as a tool to provide excellent care. Research projects have recently included studies of epidemiology and natural history to better understand disease behavior, treatments for hepatitis and acute liver failure, and eosinophilic esophagitis. The center is also involved in national studies sponsored by the National Institutes of Health (NIH), Cystic Fibrosis Foundation, Crohn’s and Colitis Foundation, and other private organizations.